Workflow
ACADIA Pharmaceuticals(ACAD) - 2024 Q3 - Earnings Call Presentation

() ACADIA Third Quarter 2024 Earnings Call November 6, 2024 Call Agenda CEO Opening Remarks Catherine Owen Adams | Chief Executive Officer Commercial Update Brendan Teehan | Chief Operating Officer, Head of Commercial R&D Update Elizabeth H.Z. Thompson | Executive Vice President, Head of Research and Development Financial Update Mark Schneyer | Chief Financial Officer Welcome Al Kildani | Senior Vice President, Investor Relations and Corporate Communications Closing Remarks Catherine Owen Adams | Chief Exec ...